Stony Brook Medicine is Now Offering a New Treatment Method for Bladder Cancer
Adstiladrin (Nadofaragene Firadenovec-vncg) is the first FDA-approved intravesical gene therapy for non-muscle invasive bladder cancer (NMIBC). This treatment is approved for patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive NMIBC with carcinoma in situ with or without papillary tumors.
Adstiladrin is instilled directly into the bladder and delivers localized, non-replicating gene therapy, resulting in anti-tumor effects. Unlike other treatment options that require frequent visits, Adstiladrin is administered via catheter once every three months.
It has been seen that more than half of patients with NMIBC carcinoma in situ had complete response to treatment and almost half of these responses were maintained after one year.
We are highly pleased to add this to our treatment armamentarium and provide more options for our patients.
Urology Ranked as 'High Performing' by U.S. News and World Report 2024-25
We are proud to announce that the Department of Urology at Stony Brook University Hospital has been rated "High Performing" by U.S. News & World Report. This rating reflects our department's performance in urological procedures and conditions, significantly surpassing national averages. We remain dedicated to delivering the highest standards of urological care to our patients.
Our Top Doctors of 2024, Named by Castle Connolly and Newsday
We are proud to share that five of our physicians have been named 'Top Doctors' by Castle Connolly and Newsday! Newsday partners with Castle Connolly's physician-led research team each year to peer-nominate 'top doctors,' who represent the top 7% of practicing physicians in the country. Congratulations to our physicians on this outstanding achievement!
 |
 |
 |
| Howard Adler, MD, FACS | Frank Darras, MD, FACS | Jason Kim, MD |
Our Physicians Partner with the Senator's Office to Offer Free Prostate Cancer Screening
On September 20th, Dr. Spaliviero, Dr. Adler, and nurse navigator Shannen Harbourne partnered with Senator Anthony Palumbo of the 1st district to offer a free prostate cancer screening to the community in honor of Prostate Cancer Awareness Month. To find more information on upcoming free screenings, please click here.
Urology Ranked Top 3% Nationally by U.S. News & World Report
Stony Brook University Hospital (SBUH) has been recognized as a Best Hospital for 2022-23 by U.S. News & World Report, ranking in the top 50 nationally for Urology, and Diabetes and Endocrinology.
SBUH ranked No. 41 nationally out of 1491 peer hospitals in Urology, which is in the top 3 percent. And SBUH ranked No. 50 nationally out of 764 peer hospitals in Diabetes and Endocrinology, which is in the top 7 percent.
SBUH also climbed to a No. 9 ranking overall in New York State out of 155 hospitals. (Last year, the hospital was ranked No. 10 in the state.) Read the full story.
New Stony Brook Urology location in Holbrook!
Stony Brook Urology has opened a new practice location and is now accepting new appointments.
Dr. Howard Adler, Dr. Steve Weissbart, Dr. Ernst, and Dr. Churukanti will be seeing patients at this location.
To schedule an appointment, please call 631-444-6270.
280 Union Avenue
Holbrook, NY 11741
